MARKET

CPRX

CPRX

Catalyst Pharmaceuticals Inc
NASDAQ
20.95
-0.67
-3.10%
After Hours: 20.90 -0.05 -0.24% 19:55 07/15 EDT
OPEN
21.71
PREV CLOSE
21.62
HIGH
21.78
LOW
20.60
VOLUME
1.39M
TURNOVER
--
52 WEEK HIGH
26.58
52 WEEK LOW
15.34
MARKET CAP
2.56B
P/E (TTM)
13.34
1D
5D
1M
3M
1Y
5Y
1D
Peering Into Catalyst Pharmaceuticals's Recent Short Interest
Benzinga · 2d ago
Weekly Report: what happened at CPRX last week (0707-0711)?
Weekly Report · 2d ago
Catalyst Pharmaceuticals Inc. Stock Rises 4.2%, Outperforms Competitors
Dow Jones · 6d ago
Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term
NASDAQ · 07/07 13:45
Weekly Report: what happened at CPRX last week (0630-0704)?
Weekly Report · 07/07 10:21
Validea Joel Greenblatt Strategy Daily Upgrade Report - 7/2/2025
NASDAQ · 07/02 09:30
Catalyst Pharmaceuticals is Now Oversold (CPRX)
NASDAQ · 07/01 20:25
Weekly Report: what happened at CPRX last week (0623-0627)?
Weekly Report · 06/30 10:24
More
About CPRX
Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing medicines for patients living with rare and difficult-to-treat diseases. The Company markets three drug products: FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone). FIRDAPSE is a treatment for people six years of age or older living with Lambert-Eaton myasthenic syndrome (LEMS). The Company, through its sub-licensee, also offers FIRDAPSE in Canada and Japan. FYCOMPA is a prescription medicine used alone or with other medicines to treat partial-onset seizures with or without secondarily generalized seizures in people with epilepsy aged four and older and with other medicines to treat primary generalized tonic-clonic seizures in people with epilepsy aged 12 and older. AGAMREE is a corticosteroid with a structure that retains the potent anti-inflammatory effects of traditional corticosteroids used in Duchenne muscular dystrophy.

Webull offers Catalyst Pharmaceuticals Inc stock information, including NASDAQ: CPRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CPRX stock methods without spending real money on the virtual paper trading platform.